Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)
about
Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.Liposomal Formulations in Clinical Use: An Updated Review.Agile delivery of protein therapeutics to CNSNKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancerThe effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents.Enhancing Anticancer Effect of Gefitinib across the Blood-Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80.Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neuronsSmuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier.New horizons in therapeutic antibody discovery: opportunities and challenges versus small-molecule therapeutics.The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.Challenges in the delivery of peptide drugs: an industry perspective.Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.Strategies to target drugs to gliomas and CNS metastases of solid tumors.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats.Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats.Improved Targeting of Cancers with Nanotherapeutics.Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.Blood-brain barrier crossing and breakthroughs in glioblastoma therapy.In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes.Recent advances in nanomedicine and survivin targeting in brain cancers.Current Challenges and Opportunities in Treating Glioblastoma.Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.Glutathione: Antioxidant Properties Dedicated to Nanotechnologies.Peptides as drug delivery vehicles across biological barriersZinc-imidazolate polymers (ZIPs) as a potential carrier to brain capillary endothelial cells
P2860
Q27316967-4176B418-1AE1-4207-9F21-12A39BD2B29CQ33850427-121DCC11-3FD2-47ED-AC89-5497C2CB3EE2Q34079647-B483A760-F990-4E0A-84E5-C35BC15D9CF1Q35805489-1AD1EC1F-347F-46D1-B998-B461F19EBED2Q36126057-7A707E29-076B-450B-BCC9-F30B85EAB821Q36212979-1362C21D-9605-4D7E-ADE5-4427B4F48EA9Q36890652-F0646E54-02C9-459E-9BBA-6991B347B59FQ38269392-7FACF13E-E429-47F3-B857-DC8F988F7CFBQ38289992-A4BC11D0-408A-4329-AF2A-3A1C1017061FQ38328927-E293CD2C-3BA6-4BF7-BA4C-E33E8E87DB68Q38351134-AA5D6974-8688-4743-9B6C-EF01E785BAF3Q38358860-675B75C6-9301-4D95-926A-0EE590E1FBB0Q38401892-318E7740-419F-40E4-8329-53AA6AAE7E71Q38610113-D02394E8-5048-4DC6-BA05-996D55222DEFQ38676164-EEB9E6EF-844A-4554-8F7B-E238B2A7CC91Q38792519-E2775260-AA24-4F2D-B53A-9C5A92501D70Q38830784-4E7283B7-550F-46B8-8363-F457EF40DE42Q38867048-887A60AF-C249-4115-B52C-0095BD1901A0Q39024233-454DC232-7CE9-486B-9E27-AB12864ABB16Q39114835-A3D854AB-0BB1-4D82-BD2C-9EA7687D1A03Q40060003-CE3DE22F-A123-4B39-9A4C-A1F959824328Q42770381-373C642F-9224-4B6F-B495-B0CFFA9DC9C6Q44331420-DFCDE021-1053-4640-920B-607D2EB57D86Q47378913-F88FB572-4106-451C-B310-DE72A8D72602Q52579808-5F96BCF4-2702-45FC-BA20-CC161C5282DFQ54118354-13ED6BD0-9CAD-41AB-8F64-069F0C416262Q55001140-A7E643F9-AAED-41AA-87F0-0C8BF54D85BFQ56889662-032C3377-A584-4352-99AC-DC5BF989BD1DQ57076402-D7DB184E-17E2-4152-AEFF-41C7B6C17D48
P2860
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@ast
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@en
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@nl
type
label
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@ast
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@en
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@nl
prefLabel
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@ast
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@en
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@nl
P2093
P2860
P3181
P1433
P1476
Pharmacokinetics, brain delive ...... iposomal doxorubicin (2B3-101)
@en
P2093
Chantal C M Appeldoorn
David Maussang
Francesca Manca
Guus A M S van Dongen
Helga E de Vries
Joan van Kregten
Olaf van Tellingen
Pieter J Gaillard
Rick Dorland
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0082331
P407
P577
2014-01-08T00:00:00Z